<PAGE>
As filed with the Securities and Exchange Commission on June 22, 1998
Registration No. ___-_____
- -------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 8-A
FOR REGISTRATION OF CERTAIN
CLASSES OF SECURITIES PURSUANT
TO SECTION 12(b) OR 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934
________________________________________
COLLATERAL THERAPEUTICS, INC.
(Exact Name of Registrant as Specified in its Charter)
DELAWARE 33-0661290
- ----------------------- ------------------------------------
(State of Incorporation (I.R.S. Employer Identification No.)
or Organization)
9360 TOWNE CENTRE DRIVE,
SAN DIEGO, CALIFORNIA 92121
(Address of Principal Executive Offices) (Zip Code)
If this form relates to the If this form relates to the
registration of a class of securities registration of a class of securities
pursuant to Section 12(b) of the pursuant to Section 12(g) of the
Exchange Act and is effective Exchange Act and is effective pursuant
pursuant to General Instruction to General Instruction A.(d), please
A.(c), please check the following check the following box. /X/
box. / /
Securities Act Registration Statement File Number
to which this form relates: 333-51029
-----------------------
(if applicable)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
------------------- -------------------------------
Not Applicable Not Applicable
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, par value $0.001 per share
- -------------------------------------------------------------------------------
(Title of class)
<PAGE>
INFORMATION REQUIRED IN REGISTRATION STATEMENT
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
See "Description of Capital Stock" in Collateral Therapeutics,
Inc.'s (the "Company") Registration Statement on Form S-1
(Registration No. 333-51029) filed with the Securities and
Exchange Commission (the "Commission") on April 24, 1998 and
any amendments to such Registration Statement on Form S-1 made
prior to the effective date (collectively, the "Registration
Statement"), each of which is incorporated herein by
reference. The form of Prospectus filed by the Company
pursuant to Rule 424(b) promulgated under the Securities Act
of 1933, as amended, shall be deemed to be incorporated by
reference into the Registration Statement
ITEM 2. EXHIBITS.
The following exhibits to this Registration Statement on Form 8-A are
incorporated by reference to the documents specified which have been or will be
filed with the Commission:
1. Form of Second Restated Certificate of Incorporation of the Company to
become effective simultaneously with the completion of the Company's
offering of shares of its Common Stock, filed as Exhibit 3.2 to the
Registration Statement.
2. Form of Restated Bylaws of the Company to become effective
simultaneously with the completion of the Company's offering of shares
of its Common Stock, filed as Exhibit 3.4 to the Registration
Statement.
3. Form of Certificate for Common Stock, filed as Exhibit 4.1 to the
Registration Statement.
4. Amended and Restated Investors' Rights Agreement, filed as
Exhibit 10.5 to the Registration Statement.
2
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this Registration Statement on Form
8-A to be signed on its behalf by the undersigned, thereto duly authorized.
COLLATERAL THERAPEUTICS, INC.
Date: June 22, 1998 By: /s/ Jack W. Reich
--------------------------
Jack W. Reich
President and Chief Executive Officer
3
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
EXHIBITS
TO
FORM 8-A
UNDER
SECURITIES EXCHANGE ACT OF 1934
COLLATERAL THERAPEUTICS, INC.
<PAGE>
EXHIBIT INDEX
-------------
The following exhibits to this Registration Statement on Form 8-A are
incorporated by reference to the documents specified which have been or will be
filed with the Commission:
<TABLE>
<CAPTION>
Exhibit
Number Exhibit
- -------- -------
<S> <C>
1. Form of Second Restated Certificate of Incorporation of the
Company to become effective simultaneously with the completion of
the Company's offering of shares of its Common Stock, filed as
Exhibit 3.2 to the Registration Statement.
2. Form of Restated Bylaws of the Company to become effective
simultaneously with the completion of the Company's offering of
shares of its Common Stock, filed as Exhibit 3.4 to the
Registration Statement.
3. Form of Certificate for Common Stock, filed as Exhibit 4.1 to the
Registration Statement.
4. Amended and Restated Investors' Rights Agreement, filed as
Exhibit 10.5 to the Registration Statement.
</TABLE>
